Promising Penny Stocks To Consider In October 2024

Global markets have shown varied performance recently, with the S&P 500 Index advancing and small-cap indices like the Russell 2000 outperforming, while European markets responded positively to interest rate cuts by the ECB. For investors interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—continue to offer intriguing opportunities. These stocks can provide a unique blend of value and growth potential when backed by strong financials, making them an interesting area for those seeking under-the-radar investment opportunities.

Top 10 Penny Stocks

Name	Share Price	Market Cap	Financial Health Rating
BP Plastics Holding Bhd (KLSE:BPPLAS)	MYR1.20	MYR337.78M	★★★★★★
DXN Holdings Bhd (KLSE:DXN)	MYR0.595	MYR2.96B	★★★★★★
Tristel (AIM:TSTL)	£3.975	£190.6M	★★★★★★
Rexit Berhad (KLSE:REXIT)	MYR0.76	MYR131.64M	★★★★★★
Lever Style (SEHK:1346)	HK$0.77	HK$488.79M	★★★★★★
Zhejiang Giuseppe Garment (SZSE:002687)	CN¥4.28	CN¥2.1B	★★★★★★
Hil Industries Berhad (KLSE:HIL)	MYR0.925	MYR307.05M	★★★★★★
Hume Cement Industries Berhad (KLSE:HUMEIND)	MYR3.54	MYR2.57B	★★★★★☆
Embark Early Education (ASX:EVO)	A$0.80	A$127.64M	★★★★☆☆
Next 15 Group (AIM:NFG)	£4.05	£404.29M	★★★★☆☆

Click here to see the full list of 5,794 stocks from our Penny Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Frontage Holdings (SEHK:1521)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Frontage Holdings Corporation is a contract research organization offering laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, with a market cap of HK$1.38 billion.

Operations: The company generates revenue from North America amounting to $198.50 million and from the People's Republic of China totaling $61.48 million.

Market Cap: HK$1.38B

Frontage Holdings Corporation, with a market cap of HK$1.38 billion, has faced challenges recently, including being dropped from the S&P Global BMI Index and reporting a net loss for the first half of 2024 despite stable sales. The company's profit margins have declined to 2.3% from 6.7% last year, and it experienced negative earnings growth over the past year. However, its debt level is satisfactory with short-term assets exceeding liabilities and operating cash flow covering debt well. Despite volatility in share price and low return on equity at 1.7%, earnings are forecasted to grow significantly by consensus estimates.

• Take a closer look at Frontage Holdings' potential here in our financial health report.
• Gain insights into Frontage Holdings' future direction by reviewing our growth report.

Antong Holdings (SHSE:600179)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Antong Holdings Co., Ltd. operates in the container shipping and logistics sector both within China and internationally, with a market cap of CN¥10.10 billion.

Operations: Antong Holdings Co., Ltd. does not have any reported revenue segments at this time.

Market Cap: CN¥10.1B

Antong Holdings, with a market cap of CN¥10.10 billion, has seen its debt to equity ratio significantly improve from 113.9% to 6.1% over five years, reflecting better financial management. Despite this progress, the company reported declining net income for the nine months ending September 2024 (CN¥161.23 million vs CN¥396.4 million last year), impacting profit margins which fell from 13.8% to 4.6%. While short-term assets cover liabilities well and cash flow adequately covers debt, earnings growth remains negative at -69.5%, and return on equity is low at 3.2%, indicating ongoing profitability challenges amidst stable revenues.

• Get an in-depth perspective on Antong Holdings' performance by reading our balance sheet health report here.
• Review our historical performance report to gain insights into Antong Holdings' track record.

Guizhou Zhongyida (SHSE:600610)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Guizhou Zhongyida Co., Ltd operates in the People's Republic of China, focusing on the production and sale of fine chemical products, with a market capitalization of CN¥3.85 billion.

Operations: Guizhou Zhongyida Co., Ltd has not reported any specific revenue segments.

Market Cap: CN¥3.85B

Guizhou Zhongyida, with a market cap of CN¥3.85 billion, has been working to reduce its losses over the past five years, achieving a 21.6% annual reduction rate. Despite being unprofitable and having a high net debt to equity ratio of 471%, it maintains sufficient cash runway for over three years due to positive free cash flow growth. The company reported half-year sales of CN¥560.37 million in 2024, down slightly from the previous year, with net loss narrowing from CN¥31.37 million to CN¥15.73 million year-over-year, indicating some progress in managing financial challenges amidst recent index exclusion events.

• Click to explore a detailed breakdown of our findings in Guizhou Zhongyida's financial health report.
• Explore historical data to track Guizhou Zhongyida's performance over time in our past results report.

Where To Now?

• Jump into our full catalog of 5,794 Penny Stocks here.
• Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com